| | DIHYDROERGOTAMINE Basic information |
| Product Name: | DIHYDROERGOTAMINE | | Synonyms: | Ergotaman-3',6',18-trione, 9,10-dihydro-12'-hydroxy-2'-methyl-5'-(phenylmethyl)-, (5'α,10α)-;DIHYDROERGOTAMINE;Dihydroergotamine (base and/or unspecified salts);9,10-Dihydroergotamine;9,10α-Dihydro-12'-hydroxy-2'-methyl-5'α-(phenylmethyl)ergotaman-3',6',18-trione;Dihydro Ergotamine Impurity 4;Levadex;DIHYDROERGOTAMINE USP/EP/BP | | CAS: | 511-12-6 | | MF: | C33H37N5O5 | | MW: | 583.69 | | EINECS: | 208-123-3 | | Product Categories: | | | Mol File: | 511-12-6.mol |  |
| | DIHYDROERGOTAMINE Chemical Properties |
| Melting point | 239° | | alpha | D20 -64°; 20546 -79° (c = 0.5 in pyridine) | | Boiling point | 641.14°C (rough estimate) | | density | 1.1992 (rough estimate) | | refractive index | 1.7500 (estimate) | | pka | 9≅+-.0.60(Predicted) |
| | DIHYDROERGOTAMINE Usage And Synthesis |
| Uses | Anti-adrenergic. | | Uses | Levadex is an intermediate in the synthesis of 2’-Epidihydroergotamine (E584910), which is an ergot alkaloid that exhibits potential neuroprotective properties against degenerative diseases. | | Definition | ChEBI: Ergotamine in which a single bond replaces the double bond between positions 9 and 10. A semisynthetic ergot alkaloid with weaker oxytocic and vasoconstrictor properties than ergotamine, it is used (as the methanesulfonic or tartaric acid salts) for the tr
atment of migraine and orthostatic hypotension. | | Brand name | D.H.E. 45 (Valeant); Migranal (Valeant)
. |
| | DIHYDROERGOTAMINE Preparation Products And Raw materials |
|
